Aruvant Sciences (Aruvant), a private company focused on developing gene therapies for rare diseases, announced the appointment of Meghan Kelton, executive director, human resources (HR), and E. Blair Clark-Schoeb, senior vice president, communications, to the Aruvant leadership team. “Ms. Kelton’s HR experience in gene therapy and Ms. Clark-Schoeb’s public company and rare disease communications know-how…